Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating the efficacy and safety of SHR0302 in patients with ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 2, Phase 3 | Status: COMPLETED